The Society for Clinical Research Sites (SCRS) has announced the addition of a patient engagement and retention platform to its member benefit package. Offered in partnership with TrialScout, the platform will help SCRS member sites build their brand with patients and sponsors, providing access to patient experience ratings and reviews and monthly analytics to optimize site operations.
Available to qualifying member sites domestically and abroad as a part of the SCRS Member Affinity Program (MAP), member sites now have access to the following services:
“TrialScout’s patient experience platform is focused on empowering site success and recognizing site excellence,” said CEO Dr. Irfan Khan. “SCRS member sites are the very sites we feel are best suited to benefit from TrialScout’s ability to enhance the patient experience in clinical research.”
“Through TrialScout, SCRS member sites will be able to gain a deeper understanding into how they are perceived by their communities and patients, and will have access to a new means to showcase their capabilities with the sponsors and CROs they work with,” said SCRS VP of global engagement, Dan Milam. “We are thrilled to add TrialScout’s patient engagement and retention platform as our second MAP offering as an additional way to enhance site sustainability.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.